SciELO - Scientific Electronic Library Online

 
vol.23 suppl.1Incidence of the retinopathy of prematurity in the low birthweightStrategies for the prevention of the posterior capsule opacification author indexsubject indexarticles search
Home Pagealphabetic serial listing  

Services on Demand

Article

Indicators

  • Have no cited articlesCited by SciELO

Related links

  • Have no similar articlesSimilars in SciELO

Share


Revista Cubana de Oftalmología

On-line version ISSN 1561-3070

Abstract

CHIANG RODRIGUEZ, Caridad; TOLEDO GONZALEZ, Yusimik; RUA MARTINEZ, Raúl  and  PEREZ PEREZ, Maritza. Therapeutic modalities for circumscribed choroidal hemangioma. Rev Cubana Oftalmol [online]. 2010, vol.23, suppl.1, pp. 590-607. ISSN 1561-3070.

The circumscribed choroidal hemangioma is a vascular tumor of the choroid that can be seen either in its circumscribed form without systemic connection or in its diffuse form, generally associated with systemic diseases. In spite of their likely congenital origin, it is usually diagnosed late when the patient is 20 to 50 years-old and if the tumor relates to exudative retinal detachment, thus emerging the first symptoms. The incidence of the circumscribed hemangioma is difficult to establish, because many patients are asymptomatic and then they are not diagnosed; with respect to the choroidal melanoma, the frequency is 1 out of 15. The management of the circumscribed choroidal hemangioma depends on the presence of symptoms; but simple observation is enough for asymptomatic individuals. The objective of the treatment is the preservation or the improvement of the visual acuity, leading the reabsorption of the subretinal fluid and the resolution of the macular edema. There is no specific treatment at present for this disease; hence, a literature review of the therapeutic modalities with their advantages and disadvantages was presented in this paper.

Keywords : Hemangioma; choroid; tumor; hamartoma.

        · abstract in Spanish     · text in Spanish     · Spanish ( pdf )

 

Creative Commons License All the contents of this journal, except where otherwise noted, is licensed under a Creative Commons Attribution License